Williford SE, Libby CJ, Ayokanmbi A, Otamias A, et al. Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells. PLoS One 2021;16:e0250649.
PMID: 33945569